IDEXX Financial Statements From 2010 to 2024

IDXX Stock  USD 477.79  0.45  0.09%   
IDEXX Laboratories financial statements provide useful quarterly and yearly information to potential IDEXX Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on IDEXX Laboratories financial statements helps investors assess IDEXX Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IDEXX Laboratories' valuation are summarized below:
Gross Profit
B
Profit Margin
0.2308
Market Capitalization
40.7 B
Enterprise Value Revenue
11.4607
Revenue
3.7 B
We have found one hundred twenty available fundamental trends for IDEXX Laboratories, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of IDEXX Laboratories regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself in the future. Market Cap is likely to rise to about 7 B in 2024. Enterprise Value is likely to rise to about 7.6 B in 2024

IDEXX Laboratories Total Revenue

3.84 Billion

Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Interest Expense of 37.7 M or Total Revenue of 3.8 B, as well as many exotic indicators such as Price To Sales Ratio of 13.22, Dividend Yield of 0.0013 or PTB Ratio of 32.61. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
This module can also supplement IDEXX Laboratories' financial leverage analysis and stock options assessment as well as various IDEXX Laboratories Technical models . Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.4 B3.3 B1.8 B
Slightly volatile
Other Current Liabilities502.6 M478.7 M279.7 M
Slightly volatile
Total Current Liabilities999.1 M951.5 M731.6 M
Slightly volatile
Property Plant And Equipment Net737.3 M702.2 M422 M
Slightly volatile
Accounts Payable116.2 M110.6 M66.6 M
Slightly volatile
Cash476.6 M453.9 M218.4 M
Slightly volatile
Non Current Assets Total1.9 B1.8 B956.5 M
Slightly volatile
Non Currrent Assets Other470.9 M448.5 M204.9 M
Slightly volatile
Cash And Short Term Investments476.6 M453.9 M267.4 M
Slightly volatile
Net Receivables480.3 M457.4 M252.3 M
Slightly volatile
Common Stock Shares Outstanding94.9 M84 M93.7 M
Slightly volatile
Liabilities And Stockholders Equity3.4 B3.3 B1.8 B
Slightly volatile
Inventory399.3 M380.3 M205.2 M
Slightly volatile
Other Current Assets213.8 M203.6 M121.1 M
Slightly volatile
Total Liabilities1.9 B1.8 B1.4 B
Slightly volatile
Total Current Assets1.6 B1.5 B846 M
Slightly volatile
Intangible Assets74.5 M84.5 M61.4 M
Slightly volatile
Short and Long Term Debt Total995.3 M947.9 M835.8 M
Slightly volatile
Short Term Debt208.6 M325 M346.6 M
Very volatile
Property Plant And Equipment Gross1.7 B1.6 B608.4 M
Slightly volatile
Common Stock Total EquityM12.3 M10 M
Slightly volatile
Common Stock9.2 M10.8 M9.9 M
Slightly volatile
Other Assets467.9 M445.6 M259.9 M
Slightly volatile
Property Plant Equipment784.2 M746.9 M430.4 M
Slightly volatile
Current Deferred Revenue25 M37.2 M30 M
Slightly volatile
Good Will206 M366 M220.8 M
Slightly volatile
Other Liabilities83.3 M122.6 M108.5 M
Slightly volatile
Long Term Debt380.8 M622.9 M462.2 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity853.7 K813 K343.2 K
Slightly volatile
Retained Earnings Total Equity4.3 B4.1 B1.9 B
Slightly volatile
Long Term Debt Total502 M798.5 M482.2 M
Slightly volatile
Capital Surpluse1.1 B1.7 B1.1 B
Slightly volatile
Deferred Long Term LiabilitiesM7.3 M34.9 M
Slightly volatile
Non Current Liabilities Other241.1 M229.6 M114 M
Slightly volatile
Short and Long Term Debt340.3 M325 M452.6 M
Slightly volatile
Long Term Investments59 M56.2 M20.5 M
Slightly volatile
Net Invested Capital1.6 B2.4 B1.4 B
Slightly volatile
Capital Stock11.7 M10.8 M10.6 M
Slightly volatile
Capital Lease Obligations115.7 M119.5 M92.4 M
Slightly volatile

IDEXX Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization120.7 M114.9 M77.6 M
Slightly volatile
Total Revenue3.8 B3.7 B2.1 B
Slightly volatile
Gross Profit2.3 B2.2 B1.2 B
Slightly volatile
Other Operating Expenses2.7 B2.6 B1.6 B
Slightly volatile
Operating Income1.2 B1.1 B527.3 M
Slightly volatile
EBIT1.2 B1.1 B523.2 M
Slightly volatile
EBITDA1.2 B1.1 B585.2 M
Slightly volatile
Cost Of Revenue1.5 B1.5 B913.7 M
Slightly volatile
Total Operating Expenses1.1 B1.1 B702.8 M
Slightly volatile
Income Before Tax1.1 B1.1 B504.3 M
Slightly volatile
Net Income887.3 M845 M395.5 M
Slightly volatile
Income Tax Expense226.9 M216.1 M108.7 M
Slightly volatile
Research Development200.5 M191 M124.1 M
Slightly volatile
Selling General Administrative194 M335.8 M218.5 M
Slightly volatile
Net Income Applicable To Common Shares820 M781 M389 M
Slightly volatile
Selling And Marketing Expenses292 M566.1 M339.1 M
Slightly volatile
Net Income From Continuing Ops417 M822.7 M381.6 M
Slightly volatile
Non Operating Income Net Other1.5 M958.5 K1.8 M
Slightly volatile
Non Recurring6.6 M7.4 MM
Slightly volatile
Tax Provision135 M212 M109.6 M
Slightly volatile
Interest Income3.7 M2.2 M11.9 M
Slightly volatile
Reconciled Depreciation107 M113.9 M91.3 M
Slightly volatile

IDEXX Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow129 M112.5 M175.3 M
Very volatile
Depreciation120.7 M114.9 M77.6 M
Slightly volatile
Capital Expenditures140.3 M133.6 M98 M
Slightly volatile
Total Cash From Operating Activities951.8 M906.5 M435 M
Slightly volatile
Net Income887.3 M845 M395.6 M
Slightly volatile
End Period Cash Flow476.6 M453.9 M218.4 M
Slightly volatile
Stock Based Compensation62.7 M59.7 M29 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.2212.59398.2127
Slightly volatile
Dividend Yield0.00130.0010.0014
Slightly volatile
Days Sales Outstanding58.145.607648.6857
Slightly volatile
Operating Cash Flow Per Share11.4610.91314.9559
Slightly volatile
Stock Based Compensation To Revenue0.00860.01630.0117
Slightly volatile
EV To Sales13.3712.72898.4712
Slightly volatile
ROIC0.180.35920.2738
Slightly volatile
Inventory Turnover2.973.86814.3749
Pretty Stable
Net Income Per Share10.6810.17314.5371
Slightly volatile
Days Of Inventory On Hand12094.360788.0736
Pretty Stable
Payables Turnover10.6913.294913.5507
Very volatile
Sales General And Administrative To Revenue0.120.09170.109
Slightly volatile
Research And Ddevelopement To Revenue0.06970.05220.0602
Pretty Stable
Cash Per Share5.745.46472.9521
Slightly volatile
POCF Ratio53.450.860841.4432
Slightly volatile
Payout Ratio0.08620.07190.081
Slightly volatile
Days Payables Outstanding38.4627.454231.2065
Pretty Stable
Income Quality0.791.07271.1616
Slightly volatile
EV To Operating Cash Flow53.9851.405642.8469
Slightly volatile
PE Ratio57.2954.560346.8116
Slightly volatile
Return On Tangible Assets0.320.30080.2338
Slightly volatile
Earnings Yield0.02110.01830.0237
Slightly volatile
Intangibles To Total Assets0.20.13820.1703
Pretty Stable
Current Ratio2.841.57141.5995
Pretty Stable
Receivables Turnover6.078.0038.1421
Very volatile
Graham Number67.1663.95921.9414
Slightly volatile
Revenue Per Share46.2844.072824.2461
Slightly volatile
Interest Debt Per Share11.5310.97849.5851
Slightly volatile
Debt To Assets0.20.29080.4466
Pretty Stable
Enterprise Value Over EBITDA44.642.474336.5204
Slightly volatile
Short Term Coverage Ratios2.652.78932.2918
Slightly volatile
Price Earnings Ratio57.2954.560346.8116
Slightly volatile
Operating Cycle179140137
Pretty Stable
Days Of Payables Outstanding38.4627.454231.2065
Pretty Stable
Dividend Payout Ratio0.08620.07190.081
Slightly volatile
Price To Operating Cash Flows Ratio53.450.860841.4432
Slightly volatile
Pretax Profit Margin0.30.28990.2137
Slightly volatile
Ebt Per Ebit1.310.96721.0033
Very volatile
Operating Profit Margin0.310.29970.2213
Slightly volatile
Effective Tax Rate0.210.20370.2302
Slightly volatile
Long Term Debt To Capitalization0.290.29560.5678
Pretty Stable
Total Debt To Capitalization0.280.38970.6339
Pretty Stable
Return On Capital Employed0.260.47530.4508
Slightly volatile
Ebit Per Revenue0.310.29970.2213
Slightly volatile
Quick Ratio1.720.95780.9438
Pretty Stable
Net Income Per E B T1.180.79630.7957
Slightly volatile
Cash Ratio0.950.4770.4341
Pretty Stable
Cash Conversion Cycle140113106
Pretty Stable
Operating Cash Flow Sales Ratio0.260.24760.1899
Slightly volatile
Days Of Inventory Outstanding12094.360788.0736
Pretty Stable
Days Of Sales Outstanding58.145.607648.6857
Slightly volatile
Cash Flow Coverage Ratios0.910.95640.7264
Slightly volatile
Fixed Asset Turnover7.065.21375.0538
Slightly volatile
Price Cash Flow Ratio53.450.860841.4432
Slightly volatile
Enterprise Value Multiple44.642.474336.5204
Slightly volatile
Debt Ratio0.20.29080.4466
Pretty Stable
Cash Flow To Debt Ratio0.910.95640.7264
Slightly volatile
Price Sales Ratio13.2212.59398.2127
Slightly volatile
Return On Assets0.270.25920.1953
Slightly volatile
Asset Turnover0.861.1231.1469
Pretty Stable
Net Profit Margin0.240.23080.1653
Slightly volatile
Gross Profit Margin0.610.59820.5697
Slightly volatile

IDEXX Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market CapB6.7 B6.9 B
Slightly volatile
Enterprise Value7.6 B7.2 B7.4 B
Slightly volatile

IDEXX Fundamental Market Drivers

Forward Price Earnings45.6621
Cash And Short Term Investments453.9 M

IDEXX Upcoming Events

5th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About IDEXX Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include IDEXX Laboratories income statement, its balance sheet, and the statement of cash flows. IDEXX Laboratories investors use historical funamental indicators, such as IDEXX Laboratories's revenue or net income, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may use each financial statement separately, they are all related. The changes in IDEXX Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IDEXX Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on IDEXX Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue37.2 M25 M
Total Revenue3.7 B3.8 B
Cost Of Revenue1.5 B1.5 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.09  0.12 
Research And Ddevelopement To Revenue 0.05  0.07 
Capex To Revenue(0.04)(0.04)
Revenue Per Share 44.07  46.28 
Ebit Per Revenue 0.30  0.31 

IDEXX Laboratories Investors Sentiment

The influence of IDEXX Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in IDEXX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IDEXX Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IDEXX Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average IDEXX Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on IDEXX Laboratories.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IDEXX Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IDEXX Laboratories' short interest history, or implied volatility extrapolated from IDEXX Laboratories options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.121
Earnings Share
10.04
Revenue Per Share
44.073
Quarterly Revenue Growth
0.088
Return On Assets
0.2283
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.